Article
Clinical features and outcome of arrhythmogenic cardiomyopathy because of a desmoglein-2 founder variant: A multicenter study.
Heart rhythm - 1 Aug 2026
Fu Bingqi, Chen Zhongli, Chen Zixian, Lin Yubi, Yang Bing, Wang Yunlong, Chen Kangyu, Zhao Xiaoyan, Zhao Xi, Zheng Yingying, Hu Dan, Shi Anteng, Li Zemeng, Hu Yuxiao, Wu Lingmin, Duru Firat, Hua Wei, Chen Liang
Abstract excerpt
BACKGROUND: Desmoglein 2 (DSG2)-associated cardiomyopathy represents a distinct subset of arrhythmogenic cardiomyopathy. A founder variant, NM_001943.5 (DSG2): c.T1592G (p.Phe531Cys), was identified with high frequency in China. OBJECTIVE: The study aimed to describe clinical features and outcomes of this founder variant. METHODS: Individuals with DSG2 c.T1592G (p.Phe531Cys) variants were recruited from 9 centers...
Topics
Join the communities discussing this publication.
